69 related articles for article (PubMed ID: 7579253)
1. [A myelopeptide (bivalfor), possessing antitumor activity].
Strelkov LA; Mikhaĭlova AA; Fonina LA; Gur'ianov SA; Petrov RV
Biull Eksp Biol Med; 1995 May; 119(5):530-2. PubMed ID: 7579253
[No Abstract] [Full Text] [Related]
2. Thiomycalolides: new cytotoxic trisoxazole-containing macrolides isolated from a marine sponge Mycale sp.
Matsunaga S; Nogata Y; Fusetani N
J Nat Prod; 1998 May; 61(5):663-6. PubMed ID: 9599273
[TBL] [Abstract][Full Text] [Related]
3. A further study of the cytotoxic constituents of a milnamide-producing sponge.
Sonnenschein RN; Farias JJ; Tenney K; Mooberry SL; Lobkovsky E; Clardy J; Crews P
Org Lett; 2004 Mar; 6(5):779-82. PubMed ID: 14986973
[TBL] [Abstract][Full Text] [Related]
4. [Endogenous immunoregulatory peptides (myelopeptides): structure, function, and mechanism of action].
Petrov RV; Mikhaĭlova AA; Fonina LA
Bioorg Khim; 1999 Nov; 25(11):811-5. PubMed ID: 10645485
[TBL] [Abstract][Full Text] [Related]
5. Oligopeptides with antitumor activity.
Liakopoulou-Kyriakides M
J Protein Chem; 1998 Aug; 17(6):559. PubMed ID: 9723760
[No Abstract] [Full Text] [Related]
6. Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives.
Mezo G; Czajlik A; Manea M; Jakab A; Farkas V; Majer Z; Vass E; Bodor A; Kapuvári B; Boldizsár M; Vincze B; Csuka O; Kovács M; Przybylski M; Perczel A; Hudecz F
Peptides; 2007 Apr; 28(4):806-20. PubMed ID: 17254668
[TBL] [Abstract][Full Text] [Related]
7. [Myelopeptide MP-5 and fluorescent derivatives: synthesis and biological activity].
Fonina LA; Az'muko AA; Kalikhevich VN; Levit ML; Ardemasova ZA; Gur'ianov SA; Belevskaia RG; Efremov MA; Treshchalina EM; Mikhaĭlova AA
Bioorg Khim; 2008; 34(4):451-6. PubMed ID: 18695716
[TBL] [Abstract][Full Text] [Related]
8. Culicinin D, an antitumor peptaibol produced by the fungus Culicinomyces clavisporus, strain LL-12I252.
He H; Janso JE; Yang HY; Bernan VS; Lin SL; Yu K
J Nat Prod; 2006 May; 69(5):736-41. PubMed ID: 16724832
[TBL] [Abstract][Full Text] [Related]
9. Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin-derived peptide.
Yang N; Lejon T; Rekdal O
J Pept Sci; 2003 May; 9(5):300-11. PubMed ID: 12803496
[TBL] [Abstract][Full Text] [Related]
10. Solid-phase synthesis and biological evaluation of a pepticinnamin E library.
Thutewohl M; Kissau L; Popkirova B; Karaguni IM; Nowak T; Bate M; Kuhlmann J; Müller O; Waldmann H
Angew Chem Int Ed Engl; 2002 Oct; 41(19):3616-20; 3516. PubMed ID: 12370908
[No Abstract] [Full Text] [Related]
11. [A novel immunoregulating hexapeptide with antineoplastic effect].
Treshchalina EM; Sedakova LA; Vlasenkova NK; Zhukova OS; Firsova GA; Mikhaĭlova LM; Kolesnikova EIu; Zimakova NI; Khabarov SV; Gerasimova GK
Vopr Onkol; 2001; 47(3):321-7. PubMed ID: 11544832
[TBL] [Abstract][Full Text] [Related]
12. [A myelopeptide, ameliorating the toxic effect of tumor cells on the functional activity of T-lymphocytes].
Strelkov LA; Mikhaĭlova AA; Fonina LA; Petrov RV
Dokl Akad Nauk; 1994 Sep; 338(1):125-6. PubMed ID: 7987236
[No Abstract] [Full Text] [Related]
13. Antineoplastic agents 365. Dolastatin 10 SAR probes.
Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
[TBL] [Abstract][Full Text] [Related]
14. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
[TBL] [Abstract][Full Text] [Related]
15. Syntheses of amamistatin fragments and determination of their HDAC and antitumor activity.
Fennell KA; Miller MJ
Org Lett; 2007 Apr; 9(9):1683-5. PubMed ID: 17397173
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships.
Mezö I; Lovas S; Pályi I; Vincze B; Kálnay A; Turi G; Vadász Z; Seprödi J; Idei M; Tóth G; Gulyás E; Otvös F; Mák M; Horváth JE; Teplán I; Murphy RF
J Med Chem; 1997 Oct; 40(21):3353-8. PubMed ID: 9341910
[TBL] [Abstract][Full Text] [Related]
17. New ferrocene containing peptide conjugates: synthesis and effect on human leukemia (HL-60) cells.
Miklán Z; Szabó R; Zsoldos-Mády V; Reményi J; Bánóczi Z; Hudecz F
Biopolymers; 2007; 88(2):108-14. PubMed ID: 17266125
[TBL] [Abstract][Full Text] [Related]
18. Aromatic oligopeptides with chlorambucil moiety--synthesis and biological evaluation.
Bartulewicz D
Acta Pol Pharm; 2005; 62(6):451-5. PubMed ID: 16583984
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity.
Kéri G; Mezô I; Vadász Z; Horváth A; Idei M; Vántus T; Balogh A; Bökönyi G; Bajor T; Teplán I
Pept Res; 1993; 6(5):281-8. PubMed ID: 7903057
[TBL] [Abstract][Full Text] [Related]
20. Myelopeptide-2 induces the resistance of T-lymphocytes to tumor suppression.
Khabarov SV; Gerasimova GK; Mikhailova AA; Petrov RV
Dokl Biol Sci; 2003; 390():282-5. PubMed ID: 12940165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
